Skip to main content

Table 2 Hepatitis B Practices related survey questions

From: Management of hepatitis B infected pregnant women: a cross-sectional study of obstetricians

Questions n (%)
(Q1) Have you ever had a pregnant patient who tested positive for HBsAg? Yes 122 (88.4)
No 10 (7.2)
Don’t know/no response 6 (4.4)
Screening
(Q2) Do you or your clinic routinely test all pregnant women for HBsAg with each pregnancy, regardless of results? Yes 130 (94.2)
No 1 (0.7)
Don’t know/no response 7 (5.1)
(Q3) Do you routinely inform HBsAg-positive pregnant women that their household and sexual contacts should be tested for hepatitis B? Yes 105 (76.1)
No 17 (12.3)
Don’t know/no response 16 (11.6)
Reporting
(Q4) Do you or your clinic routinely include a lab copy of the pregnant patient’s HBsAg test result in the medical record sent to the birth hospital prior to the expected delivery date? Yes 89 (64.5)
No 33 (23.9)
Don’t know/no response 16 (11.6)
(Q5) Do you know that California state ordinance requires all physicians to report positive HBsAg test results to the county health department? Yes 105 (76.1)
No 33 (23.9)
Don’t know/no response 0 (0.0)
Vaccination
(Q6) Do you routinely inform HBsAg-positive pregnant women that it is important for their newborn infants to receive hepatitis B immune globulin within 12 h of delivery to prevent perinatal hepatitis B transmission? Yes 124 (89.8)
No 2 (1.4)
Don’t know/no response 12 (8.7)
(Q7) Do you routinely inform HBsAg-positive pregnant women that it is important for their newborn infants to receive a birth dose of the hepatitis B vaccine within 12 h of delivery to prevent perinatal hepatitis B transmission? Yes 121 (87.7)
No 3 (2.2)
Don’t know/no response 14 (10.1)
(Q8) Do you routinely inform HBsAg-positive pregnant women that their infants need to receive the 2nd and 3rd doses of the hepatitis B vaccine at 1–2 months and 6 months of age? Yes 67 (48.6)
No 49 (35.5)
Don’t know/no response 22 (15.9)
(Q9) Do you routinely inform HBsAg-positive pregnant women that their infants should be tested for HBsAg and hepatitis B surface antibody between 9 and 18 months of age to ascertain whether the infants are immune or have been infected? Yes 28 (20.3)
No 78 (56.5)
Don’t know/no response 32 (23.2)
Patient Education
(Q10) Do you or your clinic routinely provide educational information about hepatitis B to HBsAg-positive pregnant patients? Yes 67 (48.6)
No 30 (21.7)
Don’t know/no response 41 (29.7)
Monitoring Of Hepatitis During Pregnancy
(Q11) Do you routinely measure hepatitis B DNA and/or hepatitis B e-antigen levels in HBsAg-positive pregnant patients? Yes 88 (63.8)
No 32 (23.2)
Don’t know/no response 18
(Q12) Do you routinely monitor HBsAg-positive pregnant women by performing liver enzyme tests during pregnancy? Yes 107 (77.5)
No 14 (10.1)
Don’t know/no response 17 (12.4)
Referral For Chronic HBV Management
(Q13) Do you routinely advise HBsAg-positive pregnant women to consult with a liver specialist or internist for evaluation for anti-viral therapy and lifelong monitoring for liver damage and liver cancer? Yes 84 (60.9)
No 29 (21.0)
Don’t know/no response 25 (18.1)